Previous 10 | Next 10 |
PALO ALTO, Calif. , Oct. 23, 2019 /PRNewswire/ -- Fourth Quarter 2019 Summary Oncology Systems gross orders grew 7% in dollars and 7% in constant currency; North America gross orders grew 10%; 17 Ethos ™ orders received in Europe and Australia Total company ...
Quick Take Galera Therapeutics ( GRTX ) has filed to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing superoxide dismutase mimetics [SOD]-based therapeutics for complications resulting from cancer radiotherapy. G...
Allergan (NYSE: AGN ) resumed with Market Perform rating and $180 (7% upside) price target at Bernstein. More news on: Allergan plc, Amgen Inc., Biogen Inc., Healthcare stocks news, Stocks on the move, , Read more ...
PALO ALTO, Calif. , Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/ University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials...
PALO ALTO, Calif. , Oct. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional oncology portfolio encompasses cryo and ...
Healthcare advances have come fast and furious over the past 25 years. One groundbreaking step forward was the introduction of robotically assisted surgery, pioneered by Intuitive Surgical (NASDAQ: ISRG) . Its da Vinci system, cleared by the U.S. Food and Drug Administration in 2000, b...
PALO ALTO, Calif. , Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption...
PALO ALTO, Calif. , Sept.16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has named Francis R. Facchini , M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia , Varian chief medical officer. Effective September 3, 2019 , Dr. Facchini has global ...
PALO ALTO, Calif. , Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally, Varian's Net Promotor Score improved from 71...
PALO ALTO, Calif. , Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for sale and offers uncompromised c...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...